Federal judge bans Shkreli from pharma industry
Former pharmaceutical executive Martin Shkreli’s anticompetitive scheme to maintain a monopoly over a lifesaving parasitic treatment was so egregious he must be banned from the industry for life, a New York federal court has ruled.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10